title: [Effective use of third generation fat emulsion in total parenteral nutrition program in patients with severe sepsis].
abstract: The aim of the current research was to measure the clinical efficacy of 3rd generation fat emulsion in the program of complete parenteral nutrition of patients with severe sepsis. The work demonstrates the results of treatment of 25 patients with severe sepsis divided into 2 groups depending on the way of parenteral nutrition. In the 1st group (13 patients) the parenteral nutrition was carried out by 20% glucose, 15% solution of crystallic aminoacids and 20% of 2nd generation fat emulsion. In the 2nd group (12 patients) parenteral nutrition was carried out by 20% glucose, 15% solution of crystallic aminoacids and 20% of 3rd generation fat emulsion. The parenteral nutrition of Ist and 2nd group contributed to the correction of hypermetabolism syndrome and stabilization of the nutritive status parameters. It was observed that the parenteral nutrition used in the 2nd group showed statistically higher positive effect on the parameters of systemic inflammation and cellular part of immunity, rather than parenteral nutrition used in the 1st group. It is revealed that, the used methods of complete parenteral nutrition in patients with severe sepsis effectively eliminate the hypermetabolism syndrome. Parenteral nutrition of patients with severe sepsis by 3rd generation fat emulsion has a positive effect of parapeters of systemic inflammation.
authors.forename: V N
authors.initials: VN
authors.lastname: Lukach
authors.forename: A O
authors.initials: AO
authors.lastname: Girsh
authors.forename: A B
authors.initials: AB
authors.lastname: Tolkach
authors.forename: N A
authors.initials: NA
authors.lastname: Osipovskiĭ
authors.forename: T N
authors.initials: TN
authors.lastname: Iudakova
authors.forename: A V
authors.initials: AV
authors.lastname: Glushchenko
mesh_terms: D000328:Adult; D003131:Combined Modality Therapy; D004734:Energy Metabolism; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009753:Nutritive Value; D010289:Parenteral Nutrition, Total / Q000379:methods*; D010538:Peritonitis / Q000150:complications / Q000378:metabolism / Q000601:surgery; D011182:Postoperative Care; D018805:Sepsis / Q000209:etiology / Q000378:metabolism / Q000601:surgery / Q000628:therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D005217:Fat Emulsions, Intravenous